a developer for the treatment of central nervous system
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with DVAX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then DVAX could also see price increases.
Ticker / NAME | Correlation To SUPN | 1D Price Change % | ||
---|---|---|---|---|
SUPN | 100% | -0.16% | ||
DVAX - SUPN | 34% Loosely correlated | +0.15% | ||
PBH - SUPN | 30% Poorly correlated | +0.85% | ||
AMRX - SUPN | 30% Poorly correlated | -2.38% | ||
AMPH - SUPN | 28% Poorly correlated | -4.67% | ||
AQST - SUPN | 27% Poorly correlated | -3.21% | ||
More |
Ticker / NAME | Correlation To SUPN | 1D Price Change % |
---|---|---|
SUPN | 100% | -0.16% |
central nervous system theme (4 stocks) | 64% Loosely correlated | -5.18% |
treatment theme (56 stocks) | 38% Loosely correlated | -1.12% |
pharmaceuticals theme (159 stocks) | 28% Poorly correlated | -1.94% |
Pharmaceuticals theme (308 stocks) | 15% Poorly correlated | -0.54% |
Pharmaceuticals: Other theme (235 stocks) | 14% Poorly correlated | -0.48% |